fda compounding glp-1 enforcement news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Drugs: Brand Companies Push

Learn about ADHD, anxiety, depression, and other mental health treatments

Learn how GLP-1 medications and HRT (hormone replacement therapy) work together to reduce weight gain, insulin resistance, and diabetes risk in menopause.

Learn about the new Wegovy Pill.

Metabolism Ignite and Cortisol Calming work synergistically to enhance weight loss results: by igniting fat-burning enzymes which boost metabolism, regulating your hunger hormones, and reducing stress

On December 14, 2023, "Science" magazine announced the top ten scientific breakthroughs of the year

Additionally, critical factors that shape the relationship between GLP-1RAs and cancer risk are thoroughly analyzed, including patient demographics, comorbidities, treatment regimens, and lifestyle factors, offering essential insights for developing individualized treatment protocols